Biogen Inc (NASDAQ:BIIB)

401.71
Delayed Data
As of Apr 24
 -28.57 / -6.64%
Today’s Change
275.39
Today|||52-Week Range
480.18
+18.34%
Year-to-Date
Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog
Apr 24 / Zacks.com
Ultragenyx Announces Positive Data from Triheptanoin Study - Analyst Blog
Apr 23 / Zacks.com
Intercept Pharmaceuticals Releases Data on Lead Drug - Analyst Blog
Apr 24 / Zacks.com
AbbVie Beats Earnings on Humira and HCV Sales, Ups View - Analyst Blog
Apr 23 / Zacks.com
Biogen Inc Earnings: Tecfidera Turbulance
Apr 24 / MotleyFool.com
Eli Lilly Beats on 1Q Earnings by Wide Margin, Affirms View - Analyst Blog
Apr 23 / Zacks.com
Biogen Shares Not Too Healthy After Q1 Miss
Apr 24 / Benzinga
Alexion Misses Q1 Earnings Estimates, Keeps 2015 Outlook - Analyst Blog
Apr 23 / Zacks.com
S&P 500, Nasdaq Notch New Records as Amazon, Microsoft Jump
Apr 24 / TheStreet.com
Is a Surprise Coming for Biogen (BIIB) This Earnings Season? - Tale of the Tape
Apr 23 / Zacks.com
Jim Cramer Loves Regeneron, Sees Shares Headed to $500
Apr 24 / TheStreet.com
Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog
Apr 22 / Zacks.com
Biogen Misses on 1Q Earnings, Tecfidera Falls Short - Analyst Blog
Apr 24 / Zacks.com
15 'Sustainable' Companies Not Named Apple to Buy Right Now
Apr 22 / TheStreet.com
Nasdaq Hovers at Highs but Energy Limits Gains on S&P 500
Apr 24 / TheStreet.com
Immunomedics (IMMU) Provides Update on Lead ADC Candidate - Analyst Blog
Apr 22 / Zacks.com
I'm Going to Keep Riding These Horses
Apr 24 / TheStreet.com
Will Agenus (AGEN) Disappoint in Q1 Earning Season? - Analyst Blog
Apr 22 / Zacks.com
4 Nasdaq Stocks at All-Time Highs - Analyst Blog
Apr 24 / Zacks.com
Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog
Apr 22 / Zacks.com
Biogen Misses Q1 Estimates, Shares Slide
Apr 24 / Benzinga
Kyle Bass Challenges Biogen Fumaderm Patent
Apr 22 / Benzinga
Biogen (BIIB) Stock Falls Today on Weak First Quarter Earnings Results
Apr 24 / TheStreet.com
Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampi...
Apr 22 / Zacks.com
Google, Amazon Lift Tech Sector as Nasdaq Hovers in Record Territory
Apr 24 / TheStreet.com
Will Edwards Lifesciences (EW) Top Q1 Earnings Estimates? - Analyst Blog
Apr 22 / Zacks.com
Biogen (BIIB) Misses on 1Q Earnings & Revenues - Tale of the Tape
Apr 24 / Zacks.com
Gilead May Be the Cure for the Blues
Apr 22 / TheStreet.com
Biogen (BIIB) Lagging In Pre-Market Activity
Apr 24 / TheStreet.com
Illumina (ILMN) Tops Q1 Earnings, Revenues; EPS View Up - Analyst Blog
Apr 22 / Zacks.com
April 24 Premarket Briefing: 10 Things You Should Know
Apr 24 / TheStreet.com
Actelion (ALIOF) Beats Q1 Earnings & Revenue Expectations - Analyst Blog
Apr 22 / Zacks.com
Must Watch Stocks for April 24, 2015
Apr 24 / Benzinga
Amgen Earnings Reveals Ugly Truth About Drug Pricing and Sales 'Growth'
Apr 22 / TheStreet.com
Earnings Scheduled For April 24, 2015
Apr 24 / Benzinga
Gilead May Be the Cure for the Blues
Apr 22 / TheStreet.com
Isis Pharmaceuticals' ISIS-TTR Effective in Extension Study - Analyst Blog
Apr 23 / Zacks.com
Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog
Apr 22 / Zacks.com
Acorda Reports Encouraging Data on MS Drug - Analyst Blog
Apr 23 / Zacks.com
Perrigo Beats on Q3 Earnings, Gives View, Rejects Mylan Bid - Analyst Blog
Apr 22 / Zacks.com
Emergent BioSolutions Resumes BioThrax Manufacturing - Analyst Blog
Apr 23 / Zacks.com
Bristol-Myers Announces Positive Data from Opdivo Study - Analyst Blog
Apr 21 / Zacks.com
Capricor's CAP-1002 Gets Orphan Drug Status in the U.S. - Analyst Blog
Apr 23 / Zacks.com
Pharmacyclics Announces Positive Results on Imbruvica - Analyst Blog
Apr 21 / Zacks.com
Gilead (GILD) Announces Encouraging Data on its HCV Drugs - Analyst Blog
Apr 23 / Zacks.com
C. R. Bard (BCR) Q1 Earnings: Lutonix DCB Holds the Key - Analyst Blog
Apr 21 / Zacks.com
Will Biogen's (BIIB) Earnings Streak Continue in 1Q? - Analyst Blog
Apr 23 / Zacks.com
Will Alexion's (ALXN) Soliris Drive Q1 Earnings Beat? - Analyst Blog
Apr 21 / Zacks.com
Baxter International Inc.: Where a Decline Is a Win
Apr 23 / MotleyFool.com
Actavis' Botox Upper Limb Spasticity Label Expanded by FDA - Analyst Blog
Apr 21 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account